HIGHLIGHTS
- who: Isabele Fattori Moretti and colleagues from the Laboratory of Molecular and Cellular Biology (LIM, ), Department of Neurology, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil have published the article: GBM Cells Exhibit Susceptibility to Metformin Treatment According to TLR4 Pathway Activation and Metabolic and Antioxidant Status, in the Journal: (JOURNAL) of 20/Nov/2022
- what: In this study metformin (MET) treatment used in combination with temozolomide (TMZ) in two cell lines (U87MG and A172) and stimulated with LPS was analyzed. For the analysis, a non-stained population of cells was used . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.